Overview
BCG-induced scrofuloderma is a rare complication characterized by granulomatous inflammation and ulceration in the scrotum following BCG vaccination, often seen in immunocompetent individuals with underlying tuberculosis infection 1.Diagnosis
Presence of BCG vaccination history
Clinical features include chronic scrotal ulceration and granulomatous inflammation
Histopathological examination showing granulomatous reaction with central necrosis 1Management
Primary management involves treating underlying tuberculosis with standard antitubercular therapy (e.g., isoniazid, rifampicin, ethambutol, pyrazinamide) 1
Adjunctive wound care including local wound debridement and dressings to promote healing 1Special Populations
No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 123Key Recommendations
Initiate antitubercular therapy in patients diagnosed with BCG-induced scrofuloderma to address underlying tuberculosis infection (Evidence: Strong 1)
Employ appropriate wound care measures including debridement and supportive dressings to manage scrotal ulceration (Evidence: Moderate 1)
Monitor for signs of genodermatoses with malignant potential in patients with recurrent or atypical presentations, though specific to this condition not explicitly detailed (Evidence: Expert opinion 3)References
1 Al Aboud K, Khachemoune A. Claude Huriez and his syndrome. Skinmed 2011. link
2 Verloes A, Soyeur-Broux M, Arrese-Estrada J, Piérard-Franchimont C, Dodinval P, Piérard GE. Poikiloderma, alopecia, retrognathism and cleft palate: the PARC syndrome. Is this an undescribed dominantly inherited syndrome?. Dermatologica 1990. link
3 Mallory SB, Stough DB. Genodermatoses with malignant potential. Dermatologic clinics 1987. link